Avita Medical | 1811094D - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Accuray USD 2.54M 6.49M 2024-12
Celltrion KRW 8.88B 322.47B 2025-12
Clinuvel Pharmaceuticals AUD 10.44M 11.65M 2025-12
Cochlear AUD 161.5M 69.6M 2025-12
CSL USD 401M 96.5M 2025-12
Cspc Pharmaceutical CNY 370.72M 592.81M 2025-12
Deva Holding AS TRY 583.98M 319.1M 2023-09
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Divis Laboratories Ltd INR 7.51B 1.68B 2026-03
Kangmei Pharma CNY -16.56M 12.74M 2026-03
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Laboratorios Farma EUR 103.69M 37.04M 2023-12
Malin Corporation EUR -1.1M 2.2M 2023-12
Mayne Pharma AUD -103.68M 68.4M 2024-06
Medical Developments International AUD -226K 121K 2025-12
Nanosonics AUD 9.64M 4.18M 2025-12
Neuren Pharmaceuticals AUD 15.4M 7.88M 2025-12
Organigram Holdings CAD 19.97M 57.93M 2025-12
Ovoca Bio EUR -765K 4.89M 2025-06
Pacific Edge NZD -16.66M 2.45M 2026-06
Paradigm Biopharmaceuticals AUD -23.24M 16.82M 2025-12
Pharma Mar EUR 1.53M 58.13M 2026-03
Polynovo AUD 3K 9.87M 2025-12
PYC Therapeutics AUD -22.83M 10.46M 2025-12
Qiagen NV USD 107.83M 22.21M 2025-12
Ramsay Health Care AUD 152.7M 32.4M 2025-12
ResMed USD 392.59M 44.05M 2025-12
Sartorius EUR 56.2M 37M 2026-03
Sino Biopharmaceutical CNY 3.39B 2.91B 2025-06
Telix Pharmaceuticals AUD -4.83M 2.54M 2025-12
Tilray USD -44.93M 44.61M 2025-09
Zealand Pharma A/S -379.12M 25.12M 2025-12
Zz Pientze Pharmaceu CNY 743.48M 56.45M 2026-03